Dr. Reddy's Laboratories Limited
$12.97
▲
1.53%
2026-04-22 10:12:13
www.drreddys.com
NYQ: RDY
Explore Dr. Reddy's Laboratories Limited stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$11.1 B
Current Price
$12.97
52W High / Low
$1,379.7 / $1,129
Stock P/E
17.86
Book Value
$4.78
Dividend Yield
0.65%
ROCE
19.86%
ROE
16.1%
Face Value
—
EPS
$0.73
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
27,811
Beta
0.3
Debt / Equity
18.03
Current Ratio
1.88
Quick Ratio
1.37
Forward P/E
23.75
Price / Sales
0.03
Enterprise Value
$-385.52 M
EV / EBITDA
-0.01
EV / Revenue
-0
Rating
Hold
Target Price
$14.28
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Akebia Therapeutics, Inc. | $1.43 | — | $381.73 M | — | 11% | 64.49% | $4.08 / $1.14 | $0.12 |
| 2. | Lantheus Holdings, Inc. | $83.97 | 23.41 | $5.47 B | — | 16.66% | 21.45% | $108.91 / $47.25 | $16.87 |
| 3. | Aurora Cannabis Inc. | $3.72 | — | $285.82 M | — | 1.34% | -15.51% | $9.33 / $4.29 | $6.8 |
| 4. | Amylyx Pharmaceuticals, Inc. | $17.57 | — | $2.03 B | — | -49.46% | -61.59% | $18.61 / $3.79 | $2.78 |
| 5. | Universe Pharmaceuticals INC | $3.32 | — | $1.9 M | — | -5.19% | -7.23% | $11 / $2 | $99.64 |
| 6. | Talphera, Inc. | $0.78 | — | $40.17 M | — | -52.04% | -1.15% | $1.57 / $0.38 | $0.34 |
| 7. | Tilray Brands, Inc. | $7.15 | — | $833.32 M | — | -6.01% | -63.16% | $23.2 / $3.51 | $14.89 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 87.27 B | 88.05 B | 85.45 B | 85.06 B | 83.59 B | — |
| Operating Profit | 14.33 B | 17.87 B | 16.84 B | 17.35 B | 18.71 B | — |
| Net Profit | 12.1 B | 14.37 B | 14.18 B | 15.94 B | 14.13 B | — |
| EPS in Rs | 14.53 | 17.26 | 17.03 | 19.14 | 16.97 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 325.54 B | 279.16 B | 245.88 B | 214.39 B |
| Operating Profit | 72.01 B | 65.31 B | 59.05 B | 35.92 B |
| Net Profit | 56.54 B | 55.68 B | 45.07 B | 23.57 B |
| EPS in Rs | 67.91 | 66.88 | 54.13 | 28.31 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 492.99 B | 387.52 B | 321.85 B | 292.83 B |
| Total Liabilities | 155.82 B | 106.97 B | 90.86 B | 102.3 B |
| Equity | 333.39 B | 280.55 B | 230.99 B | 190.53 B |
| Current Assets | 250.11 B | 248.05 B | 204.25 B | 181.86 B |
| Current Liabilities | 130.39 B | 96.04 B | 85.84 B | 94.02 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 46.43 B | 45.43 B | 58.88 B | 28.11 B |
| Investing CF | -58.08 B | -40.28 B | -41.37 B | -26.39 B |
| Financing CF | 18.91 B | -3.76 B | -26.86 B | -2.42 B |
| Free CF | 12.03 B | 18 B | 40.01 B | 9.06 B |
| Capex | -34.4 B | -27.43 B | -18.87 B | -19.05 B |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 16.61% | 13.54% | 14.69% | — |
| Earnings Growth % | 1.54% | 23.56% | 91.22% | — |
| Profit Margin % | 17.37% | 19.95% | 18.33% | 10.99% |
| Operating Margin % | 22.12% | 23.39% | 24.02% | 16.75% |
| Gross Margin % | 58.5% | 58.61% | 56.67% | 53.1% |
| EBITDA Margin % | 29.7% | 31.67% | 30.27% | 21.03% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2025-07-25 | $0.091 |
| 2024-07-30 | $0.0958 |
| 2023-07-28 | $0.0976 |
| 2023-07-07 | $0.0976 |
| 2022-08-01 | $0.0756 |
Stock Splits
| Date | Split |
|---|---|
| 2024-11-05 | 1:5 |